Clinical, biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab.
Systemic lupus erythematosus (SLE) is a multiorganic autoimmune disease that affects skin, osteoarticular and kidney frequently. Rituximab showed efficacy in treatment of osteoarticular and haematological SLE, but its use has been generalised for renal disease. In our case, we showed efficacy of rituximab in SLE articular disease, showing an ultrasonographic improvement.
Torrente-Segarra
V
V
Reumatólogo, Servicio de Reumatología Hospital del Mar - IMAS (Barcelona) Paseo Marítimo 23-25, 08003 Barcelona, Spain. vtorrente@santpau.es
Lisbona-Pérez
Mp
M
Rotes-Sala
D
D
Castro-Oreiro
S
S
Carbonell-Abelló
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab; D014463:Ultrasonography
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab